Literature DB >> 6641254

Initial aminoglycoside levels in the critically ill.

W R Summer, J R Michael, J J Lipsky.   

Abstract

Twenty-six consecutive patients admitted to the medical ICU with presumed sepsis or septic shock had their initial serum aminoglycoside level determined 1 h after completion of a 20-min infusion of tobramycin, 2 mg/kg. There was a poor correlation between the dose received and the measured aminoglycoside level; 59% of the patients had initial blood aminoglycoside concentrations below the recommended peak level of 5 micrograms/ml. An underestimation of the volume of distribution in critically ill patients best explains the low serum aminoglycoside levels produced by the currently recommended dosage schedule.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6641254     DOI: 10.1097/00003246-198312000-00011

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  14 in total

1.  Bayesian forecasting of serum gentamicin concentrations in intensive care patients.

Authors:  K A Rodvold; R D Pryka; P G Kuehl; R A Blum; P Donahue
Journal:  Clin Pharmacokinet       Date:  1990-05       Impact factor: 6.447

2.  Individualised aminoglycoside dosage based on pharmacokinetic analysis is superior to dosage based on physician intuition at achieving target plasma drug concentrations.

Authors:  E J Begg; H C Atkinson; G M Jeffery; N W Taylor
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

3.  Predicted and measured aminoglycoside pharmacokinetic parameters in critically ill patients.

Authors:  E Hassan; J D Ober
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

Review 4.  Once-daily aminoglycoside administration in gram-negative sepsis. Economic and practical aspects.

Authors:  S E Parker; P G Davey
Journal:  Pharmacoeconomics       Date:  1995-05       Impact factor: 4.981

Review 5.  Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.

Authors:  Federico Pea; Pierluigi Viale; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

6.  Determination of the optimum timing for pharmacokinetic monitoring of once daily aminoglycoside dosing.

Authors:  G Brown; J P McCormack
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

7.  Gentamicin volume of distribution in critically ill septic patients.

Authors:  C Triginer; I Izquierdo; R Fernández; J Rello; J Torrent; S Benito; A Net
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

8.  Studies on drug monitoring in thrice and once daily treatment with aminoglycosides.

Authors:  F Konrad; R Wagner; B Neumeister; H Rommel; M Georgieff
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

9.  Pharmacokinetics of antibiotics in critically ill patients.

Authors:  R van Dalen; T B Vree
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 10.  The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients.

Authors:  A Bodenham; M P Shelly; G R Park
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.